Detail akcie TEVA PHARMACEUT.INDUSTR.SP-ADR online

Business Summary: Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Teva Pharmaceutical Industries Ltd (ADR) revenues increased 2% to $12.55B. Net income applicable to common stockholders totaled $929M vs. loss of $1.42B. Revenues reflect United States segment increase of 9% to $6.54B, United States segment increase of 9% to $6.54B. Net Income reflects United States segment income increase of 26% to $2.18B, United States segment income increase of 26% to $2.18B.